§ 01 Overview
Overview
Compounded blend combining MOTS-C and SS-31 in a single vial for a broad mitochondrial intervention.
Individual components have preclinical/clinical data. The blend has none specifically.
§ 02 Mechanism
Mechanism of action
The blend stacks the exercise-mimetic and AMPK-activating effects of MOTS-C with the cardiolipin-stabilizing effects of SS-31, targeting both signaling and structural aspects of mitochondrial function.
- 01Combined mitochondrial signaling and structural support
- 02Convenience of single-vial administration
§ 03 Dosing
Dosing protocol
Standard Protocol
- Vial
- Compounded vial
- BAC Water
- 2 ml BAC water typical
- Dose Range
- 1 – 3 mg per dose
- Route
- SubQ
- Timing
- AM
- Frequency
- 3x per week
- Cycle
- 8 weeks
§ 04 Evidence
Evidence & research
Individual components have preclinical/clinical data. The blend has none specifically.
FDA Status
Not FDA-approved.
§ 05 Stacks
Common stacks
§ 07 Sourcing
Sourcing & supply
Regulatory status
Restricted from compounding
Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales.
No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.
Browse full supplier directory§ 09 Safety
Safety & side effects
Side effects
- 01As per components
Contraindications
None specified.
§ 10 Questions
Omega (MOTS-C + SS-31) FAQ
- What is Omega (MOTS-C + SS-31)?
- Compounded blend combining MOTS-C and SS-31 in a single vial for a broad mitochondrial intervention. The blend stacks the exercise-mimetic and AMPK-activating effects of MOTS-C with the cardiolipin-stabilizing effects of SS-31, targeting both signaling and structural aspects of mitochondrial function.
- What is Omega (MOTS-C + SS-31) used for?
- Reported uses include combined mitochondrial signaling and structural support and convenience of single-vial administration. Evidence strength is rated Experimental — see the evidence section for detail.
- How is Omega (MOTS-C + SS-31) dosed?
- Commonly referenced dosing is 1 – 3 mg per dose, typically 3x per week, administered SubQ. This is educational reference only; consult a licensed clinician before use.
- How do you reconstitute Omega (MOTS-C + SS-31)?
- For Omega (MOTS-C + SS-31), vials commonly come in Compounded vial and a common reconstitution is 2 ml BAC water. Use the reconstitution calculator to convert any vial size and water volume into exact insulin-syringe units.
- What are the side effects of Omega (MOTS-C + SS-31)?
- Commonly reported side effects include as per components. This list is not exhaustive.
- Is Omega (MOTS-C + SS-31) legal?
- Placed on the FDA's 503A Category 2 list and cannot be lawfully compounded in the US. No brand pharmacy alternative exists. US buyers encounter only research-use-only (RUO) channels, which the FDA's Intended Use Doctrine treats as unapproved drug sales. FDA status: Not FDA-approved..